Please assess the completion status of the following clinical trial:

Trial Title: Effect of Attention Training or SSRIs on Symptoms and Neural Activation in Social Anxiety

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* A signed consent form~* Men and women between the ages of 18 and 65.~* Meeting a current diagnosis of Social Anxiety Disorder (SP) according to the DSM-IV.~* SP as the primary diagnosis: In cases of co-morbidity, SP will be deemed as the most distressing and clinically significant condition among the co-morbid disorders.~* No current pharmaco-therapy.~Exclusion Criteria:~* A diagnosis of psychotic or bipolar disorders.~* A diagnosis of a neurological disorder (i.e., epilepsy, brain injury).~* Drug or alcohol abuse.~* Any current pharmacological treatment.~* Any current psychotherapeutic treatment.~* Change in treatment during the study.~* Poor judgment capacity (i.e., children under 18 and special populations).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Gaze Contingent Music Reward Therapy (Type: EXPERIMENTAL): Participants will receive gaze-contingent feedback according to their viewing patterns, over a course of 12 weeks.
- Selective Serotonin Reuptake Inhibitors (Type: ACTIVE_COMPARATOR): Participants will receive 10-20 mg of Escitalopram over a course of 12 weeks.
- Waitlist Control (Type: PLACEBO_COMPARATOR): Participants will wait for treatment for 12 weeks, then receive GC-MRT for 12 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).